ymjЯкутский медицинский журналYakut Medical Journal1813-19052312-1017ЯНЦ КМП10.25789/YMJ.2021.76.19ymj-603Research ArticleАКТУАЛЬНАЯ ТЕМАACTUAL TOPICСравнительный анализ длительности спорадических форм болезни двигательного мотонейрона в РС (Я)Comparative analysis of the duration of sporadic forms of motor neuron disease in the Republic of Sakha (Yakutia)ДавыдоваТ. К.DavydovaT. K.

Давыдова Татьяна Кимовна – к.м.н., в.н.с., руковод. Центра нейродегенеративных заболеваний

Davydova Tatiana Kimovna – Candidate of Medical Sciences, associate researcher, Director of the Center for Neurodegenerative Diseases, Head of the lab.

tanya.davydova.56@inbox.ruШадринаС. С.ShadrinaS. S.

Шадрина Светлана Семеновна – с.н.с. науч.-иссл. лаб.

Shadrina Svetlana Semyonovna – associate researcher, scientific-research lab.

svetlana.maksimo@mail.ruВарламоваМ. А.VarlamovaM. A.

Варламова Марина Алексеевна – н.с.

Varlamova Marina Alekseevna – research associate

varlamova.m@yandex.ruШнайдерН. А.SchneiderN. A.

Шнайдер Наталья Алексеевна – д.м.н., проф., в.н.с. Центра персонализированной психиатрии и неврологии; проф., в.н.с.

г. Санкт-Петербург; г. Красноярск

Schneider Natalia Alekseevna – MD, Prof., associate researcher of the Center for Personalized Psychiatry and Neurology; associate researcher

St. Petersburg; Krasnoyarsk

NASchnaider@yandex.ruГончароваП. С.GoncharovaP. S.

Гончарова Полина Сергеевна – клинический ординатор Центра персонализированной психиатрии и неврологии

г. Санкт-Петербург

Goncharova Polina Sergeevna –neurologist-resident of the Center for Personalized Psychiatry and Neurology

po.gon4arova@yandex.ruЯНЦ КМПРоссияYSC CMPRussian FederationСВФУ им. М.К. АммосоваРоссияNEFU named after M.K. AmmosovRussian FederationФГБУ «Национальный медицинский исследовательский центр психиатрии и неврологии им. В.М. Бехтерева» Минздрава России; ФГБОУ ВО Красноярский государственный медицинский университет им. профессора В.Ф. Войно-ЯсенецкогоРоссияFederal State Budgetary Institution "V.M. Bekhterev National Medical Research Center of Psychiatry and Neurology" of the Ministry of Health of Russia; Krasnoyarsk State Medical University named after V.F. Voino-YasenetskyRussian FederationФГБУ «Национальный медицинский исследовательский центр психиатрии и неврологии им. В.М. Бехтерева» Минздрава РоссииРоссияFSBI "National Medical Center"Russian Federation202104052025048186Copyright © Давыдова Т.К., Шадрина С.С., Варламова М.А., Шнайдер Н.А., Гончарова П.С., 20252025Давыдова Т.К., Шадрина С.С., Варламова М.А., Шнайдер Н.А., Гончарова П.С.Davydova T.K., Shadrina S.S., Varlamova M.A., Schneider N.A., Goncharova P.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://ymj.elpub.ru/jour/article/view/603

В статье описано исследование длительности заболевания у пациентов с разной формой болезни двигательного нейрона (БДН) в РС (Я) в зависимости от этноса, возраста и гендерной принадлежности. Полученные результаты коррелируют с данными исследователей в мире и зависят от комбинированного или изолированного поражения мотонейрона.

The article describes a study of the duration of the disease in patients with different forms of motor neuron disease (MND) in the Republic of Sakha (Yakutia), depending on ethnicity, age and gender. The obtained results correlate with the data of researchers in the world and depend on the combined or isolated lesion of the motor neuron.

болезни двигательного нейронабоковой амиотрофический склерозпрогрессирующая мышечная атрофияпервичный боковой склерозmotor neuron diseasesamyotrophic lateral sclerosisprogressive muscle atrophyprimary lateral sclerosisReferencesДавыдова T.K. Сравнительный анализ спорадических случаев и семейной формы прогрессирующей мышечной атрофии за 30-летний период (1986-2016 гг.) в РС(Я) / T.K. Давыдова, T.Я. Николаева, Л.Т. Оконешникова // Якутский медицинский журнал. - 2018. – 4 (64). - С. 110-113. DOI 10.25789/YMJ.2018.64.34.Davydova TK, Nikolaeva TYa, Okoneshnikova LT. Comparative analysis of sporadic cases and familial forms of progressive muscle atrophy over a 30-year period (1986-2016) in the Republic of Sakha (Yakutia). Yakut Medical Journal. 2018; 4 (64): 110-113. DOI 10.25789/YMJ.2018.64.34.Левицкий Г.Н. Боковой амиотрофический склероз: лечение и теоретические вопросы / Г.Н. Левицкий. – М.: Практическая медицина, 2010. – C. 562.Levitsky GN. Amyotrophic lateral sclerosis: treatment and theoretical issues. M: Practical Medicine, 2010; 562Нарушения эмоциональной сферы у пациентов с болезнью двигательного нейрона в Республике Саха (Якутия) / T.K. Давыдова, С.С. Шадрина, Н.А. Шнайдер [и др.] // Якутский медицинский журнал. - 2021. - 1 (73). - С. 110-113. DOI 10.25789/YMJ.2021.73.03Davydova TK, Shadrina SS, Schneider NA, et al. Disorders of the emotional sphere in patients with motor neuron disease in the Republic of Sakha (Yakutia). Yakut Medical Journal. 2021; 1 (73): 110-113. DOI 10.25789/YMJ.2021.73.03Хондкариан О.А. Боковой амиотрофический склероз / О.А. Хондкариан, Т.Л. Бунина, И.А. Завалишин. - М.: Медицина, 1978. – С. 264.Hondkarian OA, Bunin TL, Zavalishin IA. Amyotrophic lateral sclerosis. M: Medicine. 1978: 264.Van den Berg-Vos RM, Visser J, Kalmijn S, et al. A long-term prospective study of the natural course of sporadic adult-onset lower motor neuron syndromes Arch Neurol. 2009; 66(6): 751-757. DOI:10.1001/archneurol.2009.91Van den Berg-Vos RM, Visser J, Kalmijn S, et al. A long-term prospective study of the natural course of sporadic adult-onset lower motor neuron syndromes Arch Neurol. 2009; 66(6): 751-757. DOI:10.1001/archneurol.2009.91Juntas Morales R, Pageot N, Taieb G, et al. Adult-onset spinal muscular atrophy: An update. Rev Neurol (Paris). 2017; 73(5): 308-319. DOI:10.1016/j.neurol.2017.03.015Juntas Morales R, Pageot N, Taieb G, et al. Adult-onset spinal muscular atrophy: An update. Rev Neurol (Paris). 2017; 73(5): 308-319. DOI:10.1016/j.neurol.2017.03.015Yang X, Y. Ji, Wang W, et al. Amyotrophic Lateral Sclerosis: Molecular Mechanisms, Biomarkers, and Therapeutic Strategies Antioxidants (Basel). 2021; 10(7): 1012. DOI: 10.3390/antiox10071012Yang X, Y. Ji, Wang W, et al. Amyotrophic Lateral Sclerosis: Molecular Mechanisms, Biomarkers, and Therapeutic Strategies Antioxidants (Basel). 2021; 10(7): 1012. DOI: 10.3390/antiox10071012Matsubara T, Oda M, Takahashiet T, et al. Amyotrophic lateral sclerosis of long clinical course clinically presenting with progressive muscular atrophy. Neuropathology. 2019; Feb. 39(1): 47-53. DOI: 10.1111/neup.12523Matsubara T, Oda M, Takahashiet T, et al. Amyotrophic lateral sclerosis of long clinical course clinically presenting with progressive muscular atrophy. Neuropathology. 2019; Feb. 39(1): 47-53. DOI: 10.1111/neup.12523Bu XL, Xiang Y, Guo Y. The Role of Iron in Amyotrophic Lateral Sclerosis. Adv. Exp. Med. Biol. 2019; 1173: 145–152.Bu XL, Xiang Y, Guo Y. The Role of Iron in Amyotrophic Lateral Sclerosis. Adv. Exp. Med. Biol. 2019; 1173: 145–152.Grad LI, Rouleau GA, Ravits J, et al. Clinical Spectrum of Amyotrophic Lateral Sclerosis (ALS). Cold Spring HarbPerspect Med. 2017; 7(8): a024117. Published 2017 Aug 1. DOI:10.1101/cshperspect.a024117Grad LI, Rouleau GA, Ravits J, et al. Clinical Spectrum of Amyotrophic Lateral Sclerosis (ALS). Cold Spring HarbPerspect Med. 2017; 7(8): a024117. Published 2017 Aug 1. DOI:10.1101/cshperspect.a024117Maria Carmela Tartaglia , Ann Rowe, Karen Findlater, et al. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis:examination of symptoms and signs at disease onset and during follow-up. Arch Neurol. 2007 Feb; 64(2): 232-6. DOI: 10.1001/archneur.64.2.232.Maria Carmela Tartaglia , Ann Rowe, Karen Findlater, et al. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis:examination of symptoms and signs at disease onset and during follow-up. Arch Neurol. 2007 Feb; 64(2): 232-6. DOI: 10.1001/archneur.64.2.232.Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000; 1: 293–299.Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000; 1: 293–299.Forestier NLe, Meininger V. Primary lateral sclerosis: the era of international diagnosis criteria. Rev Neurol (Paris). 2009 May; 165(5): 415-29. DOI: 10.1016/j.neurol.2008.07.022. Epub2008 Oct 7.Forestier NLe, Meininger V. Primary lateral sclerosis: the era of international diagnosis criteria. Rev Neurol (Paris). 2009 May; 165(5): 415-29. DOI: 10.1016/j.neurol.2008.07.022. Epub2008 Oct 7.Foster LA, Salajegheh MK. Motor neuron disease: pathophysiology, diagnosis, and treatment. Am J Med. 2019; 132 (1): 32-37. DOI: 10.1016Foster LA, Salajegheh MK. Motor neuron disease: pathophysiology, diagnosis, and treatment. Am J Med. 2019; 132 (1): 32-37. DOI: 10.1016Fullam T, Statland J. Upper Motor Neuron Disorders: Primary Lateral Sclerosis, Upper Motor Neuron Dominant Amyotrophic Lateral Sclerosis, and Hereditary Spastic Paraplegia. Brain Sci. 2021 May 11; 11(5): 611. DOI: 10.3390/brainsci11050611.Fullam T, Statland J. Upper Motor Neuron Disorders: Primary Lateral Sclerosis, Upper Motor Neuron Dominant Amyotrophic Lateral Sclerosis, and Hereditary Spastic Paraplegia. Brain Sci. 2021 May 11; 11(5): 611. DOI: 10.3390/brainsci11050611.Hudson A.J. Amyotrophic lateral sclerosis: Clinical evidence of differences pathogenesis and etiology. Amyotrophic lateral sclerosis: Concepts in Pathogenesis and Etiology. 1990; 108-143.Hudson A.J. Amyotrophic lateral sclerosis: Clinical evidence of differences pathogenesis and etiology. Amyotrophic lateral sclerosis: Concepts in Pathogenesis and Etiology. 1990; 108-143.Liewluck T, David S Saperstein. Progressive Muscular Atrophy. Neurol Clin. 2015 Nov; 33(4): 761-73. DOI: 10.1016/j.ncl.2015.07.005.Liewluck T, David S Saperstein. Progressive Muscular Atrophy. Neurol Clin. 2015 Nov; 33(4): 761-73. DOI: 10.1016/j.ncl.2015.07.005.Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol. 2019; 32(5): 771-776. DOI:10.1097/WCO.0000000000000730Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol. 2019; 32(5): 771-776. DOI:10.1097/WCO.0000000000000730Norris F, Shepherd R, Denys E, et al. Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci. 1993; 118(1): 48-55. DOI: 10.1016/0022-510x(93)90245-t.Norris F, Shepherd R, Denys E, et al. Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci. 1993; 118(1): 48-55. DOI: 10.1016/0022-510x(93)90245-t.Jeffrey M Statland, Richard J Barohn, April L McVey, et al. Patterns of Weakness, Classification of Motor Neuron Disease, and Clinical Diagnosis of Sporadic Amyotrophic Lateral Sclerosis. Neurol Clin. 2015 Nov; 33(4): 735-48. DOI: 10.1016/j.ncl.2015.07.006. Epub 2015 Sep 8.Jeffrey M Statland, Richard J Barohn, April L McVey, et al. Patterns of Weakness, Classification of Motor Neuron Disease, and Clinical Diagnosis of Sporadic Amyotrophic Lateral Sclerosis. Neurol Clin. 2015 Nov; 33(4): 735-48. DOI: 10.1016/j.ncl.2015.07.006. Epub 2015 Sep 8.Mitsumoto H, Nagy PL, Gennings C, et al. Phenotypic and molecular analyses of primary lateral sclerosis. Neurol Genet. 2015; 1(1): 3. Published 2015 Apr 14. DOI: 10.1212/01.NXG.0000464294.88607.dd.Mitsumoto H, Nagy PL, Gennings C, et al. Phenotypic and molecular analyses of primary lateral sclerosis. Neurol Genet. 2015; 1(1): 3. Published 2015 Apr 14. DOI: 10.1212/01.NXG.0000464294.88607.dd.Statland JM, Barohn RJ, Dimachkie MM, et al. Primary Lateral Sclerosis. NeurolClin. 2015; 33(4): 749-760. DOI:10.1016/j.ncl.2015.07.007.Statland JM, Barohn RJ, Dimachkie MM, et al. Primary Lateral Sclerosis. NeurolClin. 2015; 33(4): 749-760. DOI:10.1016/j.ncl.2015.07.007.Fournier ChN, Murphy A, Loci L, et al. Primary Lateral Sclerosis and Early Upper Motor Neuron Disease: Characteristics of a Cross-Sectional Population. J Clin Neuromuscul Dis. - 2016 Mar; 17(3): 99-105. DOI: 10.1097/CND.0000000000000102.Fournier ChN, Murphy A, Loci L, et al. Primary Lateral Sclerosis and Early Upper Motor Neuron Disease: Characteristics of a Cross-Sectional Population. J Clin Neuromuscul Dis. - 2016 Mar; 17(3): 99-105. DOI: 10.1097/CND.0000000000000102.Meyer T, Münch C, van Landeghem FK, et al. Progressive muscle atrophy. A rarely diagnosed variant of amyotrophic lateral sclerosis. Nervenarzt. 2007; 78(12): 1383-1388. DOI:10.1007/s00115-007-2288-y.Meyer T, Münch C, van Landeghem FK, et al. Progressive muscle atrophy. A rarely diagnosed variant of amyotrophic lateral sclerosis. Nervenarzt. 2007; 78(12): 1383-1388. DOI:10.1007/s00115-007-2288-y.Ramanathan RS, Rana S. Demographics and clinical characteristics of primary lateral sclerosis: case series and a review of literature. Neurodegener Dis Manag. 2018; 8(1): 17-23. DOI:10.2217/nmt-2017-0051.Ramanathan RS, Rana S. Demographics and clinical characteristics of primary lateral sclerosis: case series and a review of literature. Neurodegener Dis Manag. 2018; 8(1): 17-23. DOI:10.2217/nmt-2017-0051.Kim WK, Liu X, Sandner J, et al. Study of 962 patients indicates progressive muscular atrophy is a form of ALS. Neurology. 2009; 73(20): 1686-1692. DOI: 10.1212/WNL.0b013e3181c-1dea3.Kim WK, Liu X, Sandner J, et al. Study of 962 patients indicates progressive muscular atrophy is a form of ALS. Neurology. 2009; 73(20): 1686-1692. DOI: 10.1212/WNL.0b013e3181c-1dea3.Swash M, Schwartz M. Neuromuscular diseases: a practical approach to diagnosis and management. Springler. New York. 1988; 456.Swash M, Schwartz M. Neuromuscular diseases: a practical approach to diagnosis and management. Springler. New York. 1988; 456.Gordon PH, Cheng B, Katz IB, et al. The natural history of primary lateral sclerosis. Neurology. 2006; 66(5): 647-653. DOI:10.1212/01.wnl.0000200962.94777.71.Gordon PH, Cheng B, Katz IB, et al. The natural history of primary lateral sclerosis. Neurology. 2006; 66(5): 647-653. DOI:10.1212/01.wnl.0000200962.94777.71.Bogucki A, Pigońska J, Szadkowska I, et al. Unilateral progressive muscular atrophy with fast symptoms progression. NeurolNeurochir Pol. 2016; 50(1): 52-4. DOI: 10.1016.Bogucki A, Pigońska J, Szadkowska I, et al. Unilateral progressive muscular atrophy with fast symptoms progression. NeurolNeurochir Pol. 2016; 50(1): 52-4. DOI: 10.1016.Marin B, Boumédiene F, Logroscino G, et al. Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int J Epidemiol. 2017 Feb 1; 46(1): 57-74. doi: 10.1093/ije/dyw061. PMID: 27185810; PMCID: PMC5407171.Marin B, Boumédiene F, Logroscino G, et al. Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int J Epidemiol. 2017 Feb 1; 46(1): 57-74. doi: 10.1093/ije/dyw061. PMID: 27185810; PMCID: PMC5407171.Wijesekera LC, Leigh PN. Amyotrophic lateral sclerosis Orphanet J.Rare Dis. 2009; Feb. 3: 4:3. DOI: 10.1186/1750-1172-4-3.Wijesekera LC, Leigh PN. Amyotrophic lateral sclerosis Orphanet J.Rare Dis. 2009; Feb. 3: 4:3. DOI: 10.1186/1750-1172-4-3.

The authors declare that there are no conflicts of interest present.